{"database": "lobbying", "table": "lobbying_activities", "rows": [[2150360, "272f7e14-9aa5-4f4c-b8af-337d3eb2a996", "Q2", "MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)", 24486, "INOVIO PHARMACEUTICALS", 2018, "second_quarter", "PHA", "Government Relations Services including developing strategies to achieve legislative goals, inclusion of MERS on list of neglected diseases at FDA", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2018-07-18T14:10:26.717000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2150360"], "units": {}, "query_ms": 0.5407549906522036, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}